Literature DB >> 21139293

Patterns and predictors of proton pump inhibitor overuse among academic and non-academic hospitalists.

Shaker M Eid1, Adel Boueiz, Suchitra Paranji, Christine Mativo, Regina Landis, Marwan S Abougergi.   

Abstract

OBJECTIVE: In the hospital setting, several studies have reported proton pump inhibitor (PPI) overuse, a majority of which is continued after discharge. In addition to being expensive, PPIs are associated with an increased risk of infections, osteoporosis and serious drug interactions. We examined the trends and predictors of PPI guidelines non-compliance among academic and non-academic hospitalists in USA. METHODS AND PATIENTS: Oral PPI prescriptions initiated by 2 academic and 2 non-academic hospitalist groups were reviewed. Prescription indications were recorded when explicitly stated in the chart. Otherwise, qualified physicians reviewed the chart to make such determination. Indications were then compared to the published guidelines. Several variables were tested to determine independent predictors of initiation and post discharge continuation of guideline non-compliant prescriptions.
RESULTS: Of the 400 PPI prescriptions 39% were guideline compliant. Academic hospitalists were significantly more compliant with PPI prescription guidelines (50 vs 29%). Gastrointestinal ulcer bleeding prophylaxis (GIP) for low risk patients was the most common indication for non-compliant prescriptions, while that of guideline compliant prescriptions was dyspepsia treatment. Independent predictors of the initiation of guideline non-compliant prescriptions were non-academic hospitalist group, PPI indication not documented in the chart, and GIP as part of the admission orderset. The latter was an independent predictor of those prescriptions continuation post-discharge (protective) in addition to non-academic hospitalists group.
CONCLUSION: Hospitalists overprescribe PPI to a level comparable to that of the non-hospitalist providers in the literature. Understanding the determinants of increased compliance among academic groups is instrumental to design interventions aimed at increasing PPI prescription compliance.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21139293     DOI: 10.2169/internalmedicine.49.4064

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  28 in total

1.  The use of proton pump inhibitors in an Italian hospital: focus on oncologic and critical non-ICU patients.

Authors:  Maria Meli; Maria Pia Raffa; Renato Malta; Ilaria Morreale; Luigi Aprea; Natale D'Alessandro
Journal:  Int J Clin Pharm       Date:  2015-08-30

2.  Proton pump inhibitors: Are we still prescribing them without valid indications?

Authors:  Farooq Akram; Yufang Huang; Valencia Lim; Paul J Huggan; Reshma A Merchant
Journal:  Australas Med J       Date:  2014-11-30

Review 3.  Cardiovascular Risk of Proton Pump Inhibitors.

Authors:  Hannah Ariel; John P Cooke
Journal:  Methodist Debakey Cardiovasc J       Date:  2019 Jul-Sep

4.  Appropriateness and Associated Factors of Stress Ulcer Prophylaxis for Surgical Inpatients of Orthopedics Department in a Tertiary Hospital: A Cross-Sectional Study.

Authors:  Haiyan Li; Ning Li; Xiaoni Jia; Yuyao Zhai; Xiaorong Xue; Yi Qiao
Journal:  Front Pharmacol       Date:  2022-06-02       Impact factor: 5.988

5.  Early referral for esophageal pH monitoring is more cost-effective than prolonged empiric trials of proton-pump inhibitors for suspected gastroesophageal reflux disease.

Authors:  David A Kleiman; Toni Beninato; Brian P Bosworth; Laurent Brunaud; Thomas Ciecierega; Carl V Crawford; Brian G Turner; Thomas J Fahey; Rasa Zarnegar
Journal:  J Gastrointest Surg       Date:  2013-11-09       Impact factor: 3.452

6.  Inappropriate use of proton pump inhibitors in a local setting.

Authors:  Christopher Tze Wei Chia; Wan Peng Lim; Charles Kien Fong Vu
Journal:  Singapore Med J       Date:  2014-07       Impact factor: 1.858

Review 7.  Strategies for Effective Discontinuation of Proton Pump Inhibitors.

Authors:  Judith Kim; John W Blackett; Daniela Jodorkovsky
Journal:  Curr Gastroenterol Rep       Date:  2018-05-16

Review 8.  How May Proton Pump Inhibitors Impair Cardiovascular Health?

Authors:  Roman A Sukhovershin; John P Cooke
Journal:  Am J Cardiovasc Drugs       Date:  2016-06       Impact factor: 3.571

9.  Feasibility of a pharmacy-led intervention to de-implement non-guideline-concordant proton pump inhibitor use.

Authors:  Jackson S Musuuza; Emily Fong; Paul Lata; Katie Willenborg; Mary Jo Knobloch; Margaret J Hoernke; Andrew R Spiel; Jessica S Tischendorf; Katie J Suda; Nasia Safdar
Journal:  Implement Sci Commun       Date:  2021-06-01

10.  A nationwide nested case-control study indicates an increased risk of acute interstitial nephritis with proton pump inhibitor use.

Authors:  Mei-Ling Blank; Lianne Parkin; Charlotte Paul; Peter Herbison
Journal:  Kidney Int       Date:  2014-03-19       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.